(Total Views: 192)
Posted On: 01/24/2019 3:29:04 PM
Post# of 36566
Re: homerbedloe #1668
Homer, that is not totally accurate. Generex will still own a controlling interest in NIO which means a percentage of the value of the new company is still with GNBT.
Following the issuance of stock dividends, Generex expects to retain a controlling interest in NuGenerex Immuno-Oncology, but the exact proportion of the shares to be held by Generex has not yet been determined.
Following the issuance of stock dividends, Generex expects to retain a controlling interest in NuGenerex Immuno-Oncology, but the exact proportion of the shares to be held by Generex has not yet been determined.
(1)
(0)
